阅读说明：本技术 一种辅助治疗阿尔兹海默症的抗氧化全营养粉 (Anti-oxidation full-nutrition powder for adjuvant therapy of Alzheimer's disease ) 是由 杨宗鑫 周敏 陈春辉 葛芸芸 张其思 于 2021-02-05 设计创作，主要内容包括：本发明公开的是一种辅助治疗阿尔兹海默症的抗氧化全营养粉,包括下述组份混合而成：复合蛋白粉、椰浆粉、燕麦纤维粉、苦荞麦粉、木瓜粉、奇亚籽粉、蒜头果油微囊粉、菊粉、诺丽果原粉、亚麻籽油微囊粉、磷脂、雨生红球藻虾青素微囊粉、藻油DHA、左旋肉碱、富硒猴头菇粉、竹叶黄酮、葛根素、牛磺酸、维生素A份、维生素D3、维生素E、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、烟酸、叶酸、泛酸、磷酸氢钙、乳酸亚铁、乳酸锌、硫酸镁、柠檬酸钠、氯化钾、安赛蜜。本发明具有全营养、配比合理的特点,还包含雨生红球藻虾青素、亚麻籽油、藻油DHA、富硒猴头菇粉等对神经系统具有修复和保护作用的功效成分,可为阿尔兹海默症患者提供各种营养支持的同时增强和改善认知能力,对阿尔兹海默症的预防、控制及辅助治疗具有显著的效果。(The invention discloses an antioxidant total nutrient powder for adjuvant therapy of Alzheimer's disease, which is prepared by mixing the following components: the feed comprises compound protein powder, coconut milk powder, oat fiber powder, tartary buckwheat powder, papaya powder, chia seed powder, garlic oil microcapsule powder, inulin, noni fruit powder, linseed oil microcapsule powder, phospholipid, haematococcus pluvialis astaxanthin microcapsule powder, algae oil DHA, L-carnitine, selenium-enriched hericium erinaceus powder, bamboo leaf flavone, puerarin, taurine, vitamin A, vitamin D3, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, nicotinic acid, folic acid, pantothenic acid, calcium hydrogen phosphate, ferrous lactate, zinc lactate, magnesium sulfate, sodium citrate, potassium chloride and acesulfame potassium. The invention has the characteristics of full nutrition and reasonable proportion, also contains the functional components with repairing and protecting effects on the nervous system, such as haematococcus pluvialis astaxanthin, linseed oil, algae oil DHA, selenium-enriched hericium erinaceus powder and the like, can provide various nutritional supports for patients with Alzheimer's disease, simultaneously enhances and improves cognitive ability, and has remarkable effects on prevention, control and adjuvant therapy of Alzheimer's disease.)

1. An antioxidant full-nutrition powder for adjuvant therapy of Alzheimer's disease is characterized by comprising the following components: 5-45 parts of compound protein powder, 2-15 parts of coconut milk powder, 1-10 parts of oat fiber powder, 0-10 parts of tartary buckwheat powder, 1-10 parts of papaya powder, 1-15 parts of chia seed powder, 0-15 parts of garlic oil microcapsule powder, 1-15 parts of inulin, 1-8 parts of noni fruit raw powder, 1-10 parts of linseed oil microcapsule powder, 1-8 parts of phospholipid, 0.1-20 parts of haematococcus pluvialis astaxanthin microcapsule powder, 1-6 parts of algae oil DHA, 0.1-3 parts of L-carnitine, 0.1-6 parts of selenium-enriched hericium erinaceus powder, 0.1-8 parts of bamboo leaf flavone, 0-8 parts of puerarin, 0.01-2 parts of taurine, 0.00001-0.008 parts of vitamin D30-0.00001 parts of vitamin E, 0-0.03 parts of vitamin B10-0.003 parts of vitamin B20-0.003 parts of vitamin B, 0-0.003 part of vitamin B60, 120-0.00001 part of vitamin B, 0-1 part of vitamin C, 0-0.05 part of nicotinic acid, 0-0.0005 part of folic acid, 0-0.01 part of pantothenic acid, 0-1 part of calcium hydrophosphate, 0-0.1 part of ferrous lactate, 0-0.2 part of zinc lactate, 0-0.5 part of magnesium sulfate, 0.01-0.5 part of sodium citrate, 0-1 part of potassium chloride and 0-0.03 part of acesulfame potassium.

2. The antioxidant total nutrient powder for assisting in treating alzheimer's disease as claimed in claim 1, wherein the antioxidant components include, but are not limited to, the above bamboo leaf flavone, haematococcus pluvialis astaxanthin microcapsule powder, selenium-enriched hericium erinaceus powder.

3. The antioxidant total nutrient powder for assisting in treating alzheimer's disease as claimed in claim 1, wherein the compound protein powder includes but is not limited to deep sea fish collagen peptide, whey protein concentrate powder, soy protein isolate powder.

Technical Field

The invention relates to an antioxidant total nutrient powder for adjuvant therapy of Alzheimer's disease, belonging to the fields of food, special medical food and the like.

Technical Field

The world health organization indicates that dementia becomes a global crisis in 2012, 1 new case of dementia is added every 4 seconds, 4400 million dementia is estimated to be suffered in 2013, 7600 million is increased by 2030, and 1.35 million is increased by 2050. The Alzheimer disease rate of the aged over 65 years old in China is 5.9%, about 700 thousands of patients exist at present, and 30 thousands of the aged in China are added to the line per year. However, the differential diagnosis of alzheimer's disease is long and inefficient, and most of the patients have missed the optimal treatment stage. Therefore, early treatment needs to be found early, and better methods are mainly prevention and combined prevention and treatment. If the early prevention and intervention are not performed, the method can bring heavy economic burden to families and society.

At present, the Alzheimer disease cannot be cured radically without specific medicines, the development of the disease is delayed mostly by a few medicines, which is not a long-term basis, the prevention through daily food therapy is a key development direction in the future, and the killing in the sprouting state through non-medicine maintenance and treatment is more favorable for the control of the Alzheimer disease.

The antioxidant total nutrient powder for adjuvant therapy of Alzheimer's disease has the effects of preventing and adjuvant therapy of Alzheimer's disease, and can provide various nutrient supports for patients or potential patients.

Disclosure of Invention

The invention aims to provide the antioxidant total nutrient powder for adjuvant therapy of Alzheimer's disease, and the product has the characteristics of total nutrition, reasonable proportion and prevention and adjuvant therapy.

An antioxidant full-nutrition powder for adjuvant therapy of Alzheimer's disease comprises the following components: 5-45 parts of compound protein powder, 2-15 parts of coconut milk powder, 1-10 parts of oat fiber powder, 0-10 parts of tartary buckwheat powder, 1-10 parts of papaya powder, 1-15 parts of chia seed powder, 0-15 parts of garlic oil microcapsule powder, 1-15 parts of inulin, 1-8 parts of noni fruit raw powder, 1-10 parts of linseed oil microcapsule powder, 1-8 parts of phospholipid, 0.1-20 parts of haematococcus pluvialis astaxanthin microcapsule powder, 1-6 parts of algae oil DHA, 0.1-3 parts of L-carnitine, 0.1-6 parts of selenium-enriched hericium erinaceus powder, 0.1-8 parts of bamboo leaf flavone, 0-8 parts of puerarin, 0.01-2 parts of taurine, 0.00001-0.008 parts of vitamin D30-0.00001 parts of vitamin E, 0-0.03 parts of vitamin B10-0.003 parts of vitamin B20-0.003 parts of vitamin B, 0-0.003 part of vitamin B60, 120-0.00001 part of vitamin B, 0-1 part of vitamin C, 0-0.05 part of nicotinic acid, 0-0.0005 part of folic acid, 0-0.01 part of pantothenic acid, 0-1 part of calcium hydrophosphate, 0-0.1 part of ferrous lactate, 0-0.2 part of zinc lactate, 0-0.5 part of magnesium sulfate, 0.01-0.5 part of sodium citrate, 0-1 part of potassium chloride and 0-0.03 part of acesulfame potassium.

An antioxidant full-nutrition powder for adjuvant therapy of Alzheimer's disease is characterized in that the antioxidant components include, but are not limited to, the bamboo leaf flavone, haematococcus pluvialis astaxanthin microcapsule powder and selenium-enriched hericium erinaceus powder.

An antioxidant full-nutrition powder for adjuvant therapy of Alzheimer's disease is provided, wherein the compound protein powder includes but is not limited to deep sea fish collagen peptide, whey protein concentrate powder, and soybean protein isolate powder.

The specific implementation mode is as follows:

the present invention will be further described with reference to specific embodiments, but the embodiments of the present invention are not limited to the following examples.

Example 1 an antioxidant complete nutrition powder for adjuvant therapy of alzheimer's disease, which comprises the following components: 8 parts of deep-sea fish collagen peptide, 8 parts of whey protein concentrate powder, 8 parts of soybean protein isolate powder, 8 parts of coconut milk powder, 5 parts of oat fiber powder, 4 parts of pawpaw powder, 8 parts of chia seed powder, 12 parts of garlic oil microcapsule powder, 8 parts of inulin, 2 parts of noni fruit raw powder, 3 parts of linseed oil microcapsule powder, 2 parts of phospholipid, 5 parts of haematococcus pluvialis astaxanthin microcapsule powder, 2 parts of algae oil DHA, 0.5 part of L-carnitine, 1 part of selenium-enriched hericium erinaceus powder, 0.5 part of bamboo leaf flavone and 0.1 part of taurine, 0.0003 part of vitamin A, 0.003 part of vitamin D30.000005 part of vitamin E, 10.001 parts of vitamin B, 20.0005 parts of vitamin B, 60.0005 parts of vitamin B, 120.000003 parts of vitamin B, 0.1 part of vitamin C, 0.01 part of nicotinic acid, 0.0001 part of folic acid, 0.002 part of pantothenic acid, 0.1 part of calcium hydrophosphate, 0.02 part of ferrous lactate, 0.01 part of zinc lactate, 0.02 part of magnesium sulfate, 0.05 part of sodium citrate, 0.02 part of potassium chloride and 0.01 part of acesulfame.

Example 2 an antioxidant total nutrient powder for adjuvant therapy of alzheimer's disease, which comprises the following components: 12 parts of deep-sea fish collagen peptide, 10 parts of whey protein concentrated powder, 10 parts of soybean protein isolate powder, 9 parts of coconut milk powder, 6 parts of oat fiber powder, 6 parts of tartary buckwheat powder, 6 parts of papaya powder, 9 parts of chia seed powder, 6 parts of garlic oil microcapsule powder, 9 parts of inulin, 4 parts of noni fruit raw powder, 5 parts of linseed oil microcapsule powder, 3 parts of phospholipid, 10 parts of haematococcus pluvialis astaxanthin powder, 3 parts of algae oil DHA, 1 part of L-carnitine, 2 parts of selenium-enriched hericium erinaceus powder, 1 part of bamboo leaf flavone, 0.5 part of puerarin, 0.2 part of taurine, 0.0006 part of vitamin A, 30.000006 parts of vitamin D, 0.005 part of vitamin E, 10.002 parts of vitamin B, 20.0008 parts of vitamin B60.001 parts of vitamin B, 000 120.000005 parts of vitamin B, 0.15 parts of vitamin C, 0.02 part of nicotinic acid, 0.2 parts of folic acid, 0.004 parts of pantothenic acid, 0.15 parts of ferrous phosphate, 0.03 parts of ferrous lactate, 0.03 parts of zinc sulfate, 0.05 parts of sodium citrate, 0.05 parts of calcium hydrogen sulfate, 1.05, Potassium chloride 0.04 parts and acesulfame potassium 0.02 parts.

Example 3 an antioxidant total nutrient powder for adjuvant therapy of alzheimer's disease, which comprises the following components: 15 parts of deep-sea fish collagen peptide, 12 parts of whey protein concentrated powder, 10 parts of soybean protein isolate powder, 12 parts of coconut milk powder, 8 parts of oat fiber powder, 7 parts of tartary buckwheat powder, 8 parts of papaya powder, 10 parts of chia seed powder, 1 part of garlic oil microcapsule powder, 10 parts of inulin, 6 parts of noni fruit raw powder, 6 parts of linseed oil microcapsule powder, 4 parts of phospholipid, 15 parts of haematococcus pluvialis astaxanthin powder, 5 parts of algae oil DHA, 1.5 parts of L-carnitine, 3 parts of selenium-enriched hericium erinaceus powder, 3 parts of bamboo leaf flavone, 2 parts of puerarin, 0.3 part of taurine, 0.001 part of vitamin A, 30.000008 parts of vitamin D, 0.01 part of vitamin E, 10.002 parts of vitamin B20.001 parts of vitamin B60.002 parts, 120.000008 parts of vitamin B, 0.2 part of vitamin C, 0.03 part of nicotinic acid, 0.0004 part of folic acid, 0.008 part of pantothenic acid, 0.2 part of ferrous phosphate, 0.2 part of zinc lactate, 0.05 part of zinc lactate, 0.15 part of calcium lactate, 1.15 parts of sodium lactate, 1.15 parts of calcium lactate, 1.15 parts of sodium citrate and magnesium, Potassium chloride 0.1 part and acesulfame potassium 0.02 part.

Finally, it should be noted that the present invention is not limited to the above embodiments, and many variations are possible. All modifications which can be derived or suggested by a person skilled in the art from the disclosure of the present invention are to be considered within the scope of the invention.